{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T16:55:17Z","timestamp":1758905717238},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.ygyno.2008.05.008","type":"journal-article","created":{"date-parts":[[2008,7,2]],"date-time":"2008-07-02T14:20:34Z","timestamp":1215008434000},"page":"329-335","source":"Crossref","is-referenced-by-count":17,"title":["Paclitaxel poliglumex and carboplatin as first-line therapy in ovarian, peritoneal or fallopian tube cancer: A phase I and feasibility trial of the Gynecologic Oncology Group"],"prefix":"10.1016","volume":"110","author":[{"given":"Mark A.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Darcy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koen","family":"DeGeest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Bookman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James K.","family":"Aikins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael W.","family":"Sill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Mannel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Allievi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merrill J.","family":"Egorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2008.05.008_bib1","doi-asserted-by":"crossref","unstructured":"DuBois A., Quinn M., Thigpen T, et al., 2004 Consensus statements on the management of ovarian cancer: Final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol 2005;16 VIII 7\u201312.","DOI":"10.1093\/annonc\/mdi961"},{"key":"10.1016\/j.ygyno.2008.05.008_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ygyno.2006.09.012","article-title":"Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer","volume":"103","author":"Alberts","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2008.05.008_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/pon.1245","article-title":"Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: a literature review","volume":"17","author":"Lemieux","year":"2007","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.ygyno.2008.05.008_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF01262572","article-title":"Changes in self-concept and body image during alopecia induced cancer chemotherapy","volume":"5","author":"Munstedt","year":"1997","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ygyno.2008.05.008_bib5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1182\/blood.V97.3.638","article-title":"Investigating the platelet-sparing mechanism of paclitaxel\/carboplatin combination chemotherapy","volume":"97","author":"Pertussini","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ygyno.2008.05.008_bib6","first-page":"1038","article-title":"Phase I and pharmacokinetic study of ABI-007, a cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel","volume":"8","author":"Ibrahim","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2008.05.008_bib7","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1158\/1078-0432.CCR-03-0655","article-title":"Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies","volume":"10","author":"Kim","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2008.05.008_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ejca.2003.11.027","article-title":"Real-time pharmacokinetics guiding clinical decisions: Phase I study of a weekly schedule of liposome with solid encapsulated paclitaxel in patients tumours","volume":"40","author":"Soepenberg","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ygyno.2008.05.008_bib9","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/00001813-199608000-00004","article-title":"Synthesis and evaluation of water-soluble polyethelence glycol-paclitaxel conjugate as a paclitaxel prodrug","volume":"7","author":"Li","year":"1996","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ygyno.2008.05.008_bib10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s002800000168","article-title":"Biodistribution of paclitaxel and poly(l-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor","volume":"46","author":"Li","year":"2000","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ygyno.2008.05.008_bib11","first-page":"2404","article-title":"Complete regression of well-established tumors using a novel water-soluble poly(l-glutamic acid)-paclitaxel conjugate","volume":"58","author":"Li","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2008.05.008_bib12","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1200\/JCO.2004.12.043","article-title":"Phase II study of CT-2103 in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma","volume":"22","author":"Sabbatini","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2008.05.008_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00280-004-0938-3","article-title":"Phase I study of the novel taxane CT-2103 in patients with advanced solid tumors","volume":"55","author":"Veronese","year":"2005","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ygyno.2008.05.008_bib14","doi-asserted-by":"crossref","first-page":"7834","DOI":"10.1158\/1078-0432.CCR-05-0803","article-title":"A phase I and pharmacokinetic study of paclitaxel poliglumex (Xyotax), investigating both 3-weekly and 2-weekly schedules","volume":"11","author":"Boddy","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2008.05.008_bib15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3816\/CLC.2004.s.020","article-title":"CT-2103: A novel macromolecular taxane with potential advantages compared with conventional taxanes","volume":"6","author":"Langer","year":"2004","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ygyno.2008.05.008_bib16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/07357900500359935","article-title":"Phase I study of CT-2103, a polymer-conjugated paclitaxel and carboplatin in patients with advanced solid tumors","volume":"23","author":"Nemanaitis","year":"2005","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ygyno.2008.05.008_bib17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2008.05.008_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/jnci\/djh081","article-title":"Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer)","volume":"96","author":"Rustin","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2008.05.008_bib19","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A gynecologic oncology group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2008.05.008_bib20","first-page":"2486","article-title":"Phase I clinical and pharmacokinetic study of taxol","volume":"47","author":"Wiernik","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2008.05.008_bib21","first-page":"39","article-title":"Hepatic metabolism and biliary excretion of taxol in rats and humans","volume":"15","author":"Monsarrat","year":"1993","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ygyno.2008.05.008_bib22","first-page":"1231","article-title":"Pharmacokinetics of carboplatin after IV administration","volume":"71","author":"Elferink","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.ygyno.2008.05.008_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2165\/00003088-199121040-00002","article-title":"Clinical pharmacokinetics of carboplatin","volume":"21","author":"van der Vijgh","year":"1991","journal-title":"Clin Pharmacokinetics"},{"key":"10.1016\/j.ygyno.2008.05.008_bib24","first-page":"549","article-title":"Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxel","volume":"2","author":"Obasaju","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2008.05.008_bib25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1200\/JCO.1999.17.2.676","article-title":"Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancer","volume":"17","author":"Belani","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2008.05.008_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00280-006-0296-4","article-title":"In vitro and in vivo metabolism of paclitaxel poliglumex: identification of metabolites and active proteases","volume":"59","author":"Shaffer","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ygyno.2008.05.008_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/nano.2006.1.4.375","article-title":"Biological and clinical characterization of paclitaxel poliglumex (PPX, CT-2103), a macromolecular polymer-drug conjugate","volume":"1","author":"Chipman","year":"2006","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.ygyno.2008.05.008_bib28","doi-asserted-by":"crossref","unstructured":"T.J. Smith, J. Khatcheressian, G.H. Lyman, et al., 2006 Update of recommendations for use of white blood cell growth factors: An evidence-based clinical practice guideline. J.Clin Oncol 2006;24:3187\u20133205.","DOI":"10.1200\/JCO.2006.06.4451"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808003739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825808003739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T08:53:09Z","timestamp":1557651189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825808003739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0090825808003739"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2008.05.008","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}